References
- Ceresoli GL, Bombardieri E, D’Incalci M. Mesothelioma. Springer International Publishing; 2019.
- Carbone M, Adusumilli PS, Alexander HR, et al. Mesothelioma: scientific clues for prevention, diagnosis, and therapy. CA Cancer J Clin. 2019;69:402–429. doi:10.3322/caac.2157231283845
- Cavone D, Caputi A, De Maria L, et al. Epidemiology of mesothelioma. Environments. 2019l;6:76. doi:10.3390/environments6070076
- Cummings KJ, Becich MJ, Blackley DJ, et al. Workshop summary: potential usefulness and feasibility of a US National Mesothelioma Registry. Am J Ind Med. 2020;63:105–114. doi:10.1002/ajim.2306231743489
- van Gerwen M, Alpert N, Flores R, Taioli E. An overview of existing mesothelioma registries worldwide, and the need for a US registry. Am J Ind Med. 2020;63:115–120. doi:10.1002/ajim.2306931701555
- Arachi D, Furuya S, David A, et al. Development of the “national asbestos profile” to eliminate asbestos-related diseases in 195 countries. Int J Environ Res Public Health. 2021;18:1804. doi:10.3390/ijerph1804180433673264
- Lin RT, Chang YY, Wang JD, Lee LJ. Upcoming epidemic of asbestos-related malignant pleural mesothelioma in Taiwan: a prediction of incidence in the next 30 years. J Formos Med Assoc. 2019;118:463–470. doi:10.1016/j.jfma.2018.07.01330072200
- Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br J Can. 1999;79:666–672. doi:10.1038/sj.bjc.6690105
- Banaei A, Auvert B, Goldberg M, Gueguen A, Luce D, Goldberg S. Future trends in mortality of French men from mesothelioma. Occup Environ Med. 2000;57:488–494. doi:10.1136/oem.57.7.48810854503
- Morinaga K, Kishimoto T, Sakatani M, Akira M, Yokoyama K, Sera Y. Asbestos-related lung cancer and mesothelioma in Japan. Ind Health. 2001;39:65–74. doi:10.2486/indhealth.39.6511341560
- Marinaccio A, Montanaro F, Mastrantonio M, et al. Predictions of mortality from pleural mesothelioma in Italy: a model based on asbestos consumption figures supports results from age‐period‐cohort models. Int J Cancer. 2005;115:142–147. doi:10.1002/ijc.2082015645436
- Murayama T, Takahashi K, Natori Y, Kurumatani N. Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age‐cohort model. Am J Ind Med. 2006;49:1–7. doi:10.1002/ajim.2024616362942
- Pedra F, Tambellini AT, Pereira BD, Carioca Da Costa AC, Albuquerque de Castro H. Mesothelioma mortality in Brazil, 1980–2003. Int J Occup Environ Health. 2008;14:170–175. doi:10.1179/oeh.2008.14.3.17018686716
- Pitarque S, Cleries R, Martinez JM, Lopez-Abente G, Kogevinas M, Benavides FG. Mesothelioma mortality in men: trends during 1977–2001 and projections for 2002–2016 in Spain. Occup Environ Med. 2008;65:279–282. doi:10.1136/oem.2007.03476917890299
- Van den Borre L, Deboosere P. Asbestos in Belgium: an underestimated health risk. The evolution of mesothelioma mortality rates (1969–2009). Int J Occup Environ Health. 2014;20:134–140. doi:10.1179/2049396714Y.000000005824999848
- Tomasallo CD, Christensen KY, Raymond M, Creswell PD, Anderson HA, Meiman JG. An occupational legacy: malignant mesothelioma incidence and mortality in Wisconsin. J Occup Environ Med. 2018;60:1143–1149. doi:10.1097/JOM.000000000000146130256306
- Lilienfeld DE, Gunderson PD. The” missing cases” of pleural malignant mesothelioma in Minnesota, 1979–81: preliminary report. Public Health Rep. 1986;101:395–399.3090605
- Davis LK, Martin TR, Kligler B. Use of death certificates for mesothelioma surveillance. Public Health Rep. 1992;107:481–483.1641448
- Bruno C, Combat P, Maiozzi P, Vetrugno T. Accuracy of death certification of pleural mesothelioma in Italy. Eur J Epidemiol. 1996;12:421–423. doi:10.1007/BF001453088891549
- Iwatsubo Y, Matrat M, Michel E, et al. Estimation of the incidence of pleural mesothelioma according to death certificates in France. Am J Ind Med. 2002;42:188–199. doi:10.1002/ajim.1009812210688
- Pinheiro GA, Antao VC, Monteiro MM, Capelozzi VL, Terra-Filho M. Mortality from pleural mesothelioma in Rio de Janeiro, Brazil, 1979–2000: estimation from death certificates, hospital records, and histopathologic assessments. Int J Occup Environ Health. 2003;9:147–152. doi:10.1179/oeh.2003.9.2.14712848243
- Camidge DR, Stockton DL, Bain M. Factors affecting the mesothelioma detection rate within national and international epidemiological studies: insights from Scottish linked cancer registry-mortality data. Br J Can. 2006;95:649–652. doi:10.1038/sj.bjc.6603293
- Wojcik NC, Schnatter AR, Huebner WW. Mesothelioma in occupational cohort studies: methodological considerations. J Occup Environ Med. 2014;56:47–51. doi:10.1097/JOM.000000000000005924351897
- Anderson RN, Miniño AM, Hoyert DL, Rosenberg HM. Comparability of Cause of Death Between ICD–9 and ICD–10: Preliminary Estimates. National Vital Statistics Reports; Vol 49 No. 2. Hyattsville, Maryland: National Center for Health Statistics; 2001.
- Office for National Statistics. Results of the ICD-10 bridge coding study, England and Wales 1999. Health Stat Q. 2002;14:75–83.
- Anderson RN, Rosenberg HM. Disease classification: measuring the effect of the Tenth Revision of the International Classification of Diseases on cause‐of‐death data in the United States. Stat Med. 2003;22:1551–1570. doi:10.1002/sim.151112704615
- Lu TH. Effects of changes in underlying cause of death selection rules on the analysis of cause-specific mortality trends. Taiwan J Public Health. 2020;39:469–477.
- Lu TH. Impact of automated coding system implementation based on ICD-10 on mortality statistics in Taiwan: a bridge coding study. Taiwan J Public Health. 2020;39:578–597.
- Percy C, Stanek E, Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health. 1981;71:242–250. doi:10.2105/AJPH.71.3.2427468855
- Tai SY, Wu J, Lee LJH, Lu TH. Which ICD‐9 codes were assigned for malignant mesothelioma in the mortality data in the United States before the ICD‐10 was introduced? Am J Ind Med. 2021. doi:10.1002/ajim.23309